IE
IE · IE · IE-PA-EU/1/21/1602/001
Uplizna 100 mg concentrate for solution for infusion
ATC L04AA47
Last synced from HPRA (Ireland) on
Identification
ManufacturerAmgen Europe B.V.,
CountryIE (IE)
ATC codeL04AA47
Dispensing—
ReimbursedNo
SourceHPRA (Ireland)
Last synced6/8/2026
Packs · 1
- ie_pa_numberEU/1/21/1602/001
Annotations
No annotations yet.
Raw payload (JSON)
{
"form": "Concentrate for solution for infusion",
"routes": [
"Intravenous use"
],
"source": "hpra",
"atc_all": [
"L04AA",
"L04AA47"
],
"strength": null,
"pa_number": "EU/1/21/1602/001",
"substances": [
"Inebilizumab"
],
"legal_basis": "Known active substance (Article 8(3) of Directive No 2001/83/EC)",
"market_info": "Unknown",
"authorised_at": "25/04/2022",
"dispensing_status": "Product subject to prescription which may not be renewed (A)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}Related drugs
Other records sharing ATC code L04AA47.
Access this data programmatically
Query Uplizna 100 mg concentrate for solution for infusion and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.